Olipop is a prebiotic soda brand transforming the beverage industry by offering a healthier, science-backed alternative to traditional sodas. Made with a blend of prebiotics, botanicals, and fiber, Olipop is designed to support gut health while delivering the bold, familiar flavors of classic soft drinks. With significantly less sugar and no artificial additives, it provides a refreshing and functional tonic for health-conscious consumers. Backed by clinical research, Olipop continues to expand its product lineup and distribution, solidifying its place in the better-for-you beverage movement.
Olipop has raised $50 million in a Series C funding round at a valuation of $1.85 billion. The new round was led by J.P. Morgan Private Capital’s Growth Equity Partners. Olipop intends to use the investment to expand its product range, enhance marketing efforts, and broaden the distribution of its sodas.
Olipop, Oakland, California, United States, was founded in 2017 by Ben Goodwin and David Lester. The company operates primarily in the U.S. market, with its prebiotic sodas available in over 50,000 retail locations, including major chains like Target, Walmart, Whole Foods, and Amazon. With its commitment to innovation, health-conscious ingredients, and nationwide expansion, Olipop is shaping the future of the beverage industry, proving that soda can be both delicious and beneficial.
Share this post